A real-world retrospective cohort study comparing brand-name febuxostat (feburic) and generic febuxostat (feuri). [PDF]
Tsai SF, Wu MJ, Chen CH.
europepmc +1 more source
Effects of Citrate Mixture on Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Underexcretion-Type Gout Patients: A Prospective Cohort Study. [PDF]
Xu L +15 more
europepmc +1 more source
Allopurinol Versus Febuxostat Use and the Risk of Cardiovascular Disease in People With Chronic Kidney Disease: A New-User Active Comparator Cohort Study. [PDF]
Inoue R +5 more
europepmc +1 more source
Efficacy and Safety of Sonidegib in the Treatment of Multiple Facial Cutaneous Basal Cell Carcinomas with Chronic Renal Insufficiency: A Case Report. [PDF]
Jing W +6 more
europepmc +1 more source
Development of a green chemistry based bioanalytical method using response surface methodology to analyze febuxostat and indomethacin in rabbit plasma. [PDF]
Ansary A +7 more
europepmc +1 more source
Febuxostat may decrease the incidence of COVID-19 infection among patients with gout: a retrospective cohort study. [PDF]
Wang W +5 more
europepmc +1 more source
Advances in the management of gout: From current strategies to emerging therapies. [PDF]
Zhao Q, Dai X.
europepmc +1 more source
Effectiveness and Safety of the Novel Selective Urate Reabsorption Inhibitor Dotinurad After Switching from Febuxostat in Patients with Stage B/C Heart Failure. [PDF]
Murakami T +4 more
europepmc +1 more source
Therapeutic Strategies for Hyperuricemia: From Small-Molecule Inhibitors to RNA Therapeutics. [PDF]
Yu X, Zhang M, Huang Y.
europepmc +1 more source
Febuxostat Versus Allopurinol Use in Gout Patients: A Real-World Study. [PDF]
Voskamp J, Tausche AK.
europepmc +1 more source

